Radiosensitization of mouse sarcoma cells by fludarabine (F-ara-A) or gemcitabine (dFdC), two nucleoside analogues, is not mediated by an increased induction or a repair inhibition of DNA double-strand breaks as measured by pulsed-field gel electrophoresis

International Journal of Radiation Biology

Volumn 73, Issue 5, 1998, Pages 511-520

  Gregoire V ^a   Bruduin, M ^b   Bruniaux, M ^b   De Coster, B ^a   Octave Prignot, M ^a   Scalliet, P ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b Hospital de Jolimont   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

FLUDARABINE; GEMCITABINE;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; CELL VIABILITY; DNA REPAIR; DNA STRAND BREAKAGE; DRUG EFFECT; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY; SARCOMA CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; DNA DAMAGE; DNA REPAIR; DNA, NEOPLASM; ELECTROPHORESIS, GEL, PULSED-FIELD; FIBROSARCOMA; MICE; MICE, INBRED C3H; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; TUMOR CELLS, CULTURED; VIDARABINE;

EID: 7144264394     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/095530098142059     Document Type: Article

References (51)

1. BRYANT, P. E. and BLÖCHER, D., 1982, The effects of 9-β-D-arabinofuranosyladenine on the repair of DNA strand breaks in X-irradiated Ehrlich ascites tumour cells. International Journal of Radiation Biology, 42, 385-394.
2. BRYANT, P. E., 1984, Effects of ara-A and fresh medium on chromosome damage and DNA double-strand break repair in X-irradiated stationary cells. British Journal of Cancer, 49 (suppl. VI), 61-65.
3. CATAPANO, C. V., CHANDLER, K. B. and FERNANDES, D. J., 1991, Inhibition of primer RNA formation in CCRF-CEM cells by fludarabine triphosphate. Cancer Research, 51, 1829-1835.
4. DANHAUSER, L., PLUNKETT, W., KEATING, M. and CABANILLAS, F. 1986, 9-β-D-arabinofuranosyl-2-fluroadenine-5′-monophosphate pharmacokineties in plasma and tumours cells of patients with relapsed leukemia and lymphoma. Cancer Chemotherapy and Pharmacology, 18, 145-152.
5. ELSHAIKH, M., HUNTER, N., MILAS, W., ANG, K. K. and MASON, K., 1997, Time dependent modulation of jejunal radioresponse with gemcitabine. Proceedings of the 45th Annual Meeting of the Radiation Research Society, 228.
6. FUJII, T., HUNTER, N., ELSHAIKH, M., HITTELMAN, W., PLUNKETT, W., ANG, K. and MILAS, L., 1997, Gemcitabine improves the therapeutic ratio of radiotherapy in mouse tumours after single dose irradiation. Proceedings of the 45th Annual Meeting of the Radiation Research Society, 229.
7. GANDHI, V. and PLUNKETT, W. 1989, Interaction of arabinosyl nucleotides in K562 human leukemia cells. Biochemistry and Pharmacology, 38, 3351-3558.
8. GRÉGOIRE, V., BEAUDUIN, M., ROSIER, J-F., DE COSTER, B., BRUNIAUX, M., OCTAVE-PRIGNOT, M. and SCALLIET, P., 1997, Kinetics of mouse jejunum radiosensitization by 2′,2′-difluorodeoxycytidine (gemcitabine) and its relationship with pharmacodynamics of DNA synthesis inhibition and cell cycle redistribution in crypt cells. British Journal of Cancer, 76, 1315-1321.
9. GRÉGOIRE, V., DE BAST, M., ROSIER, J. F., BEAUDUIN, M., BRUNIAUX, M., DE COSTER, B. and SCALLIET, P., 1996, Influence of deoxycytidine kinase activity in in vitro radiosensitization by fludarabine and gemcitabine. Proceedings of the American Association for Cancer Research, 37, 612.
10. GRÉGOIRE, V and HITTELMAN, W., 1997, Xucleoside analogs as radiosensitizing agents. In Nucleoside Analogs In Cancer Therapy, edited by B. D. Cheson, M. J. Keating and W. Plunkett (New York: Marcel Dekker), pp. 315-358.
11. GRÉGOIRE, V., HUNTER, N., BROCK, W. A., MILAS, L., PLUNKETT, W. and HITTELMAN, W. N., 1994b, Fludarabine improves the therapeutic ratio of radiotherapy in mouse tumours after single dose irradiation. International Journal of Radiation Oncology, Biology, Physics, 30, 363-371.
12. GRÉGOIRE, V., HUNTER, N., MILAS, L., BROCK, W. A., PLUNKETT, W. and HITTELMAN, W. N., 1994a, Potentiation of radiation-induced regrowth delay in murine tumours by fludarabine. Cancer Research, 54, 468-474.
13. GRÉGOIRE, V., RUIFROK, A. C. C., PRICE, R. E., BROCK, W. A., HITTELMAN, W. N., PLUNKETT, W. K. and ANG, K. K., 1995, Effect of intra-peritoneal fludarabine administration on rat spinal cord tolerance to fractionated irradiation. Radiotherapy and Oncology, 36, 50-55.
14. GRÉGOIRE, V., VAN, N. T., BROCK, W. A., MILAS, L., PLUNKETT, W. and HITTELMAN, W. N., 1994c, The role of fludarabine-induced apoptosis and cell cycle synchronization in enhanced murine tumours radiation response in vivo. Cancer Research, 54, 6201-6209.
15. HEINEMANN, V., HERTEL, L. W., GRINDEY, G. B. and PLUNKETT W., 1988, Comparison of the cellular pharmacokinetics and toxicity of 2′,2′-difluorodeoxycytidine and 1-β-D-arabinofuranosylcytosine. Cancer Research, 48, 4024-4031.
16. HEINEMANN, V., XU, Y-Z., CHUBB, S., SEN, A., HERTEL, L. W., GRINDEY, G. B. and PLUNKETT, W., 1992. Cellular elimination of 2′,2′-difluorodeoxycytidine 5′-triphosphate: a mechanism of self-potentiation. Cancer Research, 52, 533-539.
17. HISS, F. A. and PRESTON R. J., 1977, The effect of cytosine arabinoside on the frequency of single strand breaks in mammalian cells following irradiation or chemical treatment. Biochimica et Biophysica Acta, 478, 1-8.
18. HITTELMAN, W. N., FUJII, T., HUNTER, N., KONISHI, H., MASON, K., GRÉGOIRE, V., PLUNKETT, W. and MILAS, L., 1996, Identification of a window of therapeutic opportunity for the combination of gemcitabine and radiation. Proceedings of the American Association for Cancer Research, 37, 290.
19. HUANG, N. J. and HITTELMAN, W. N., 1995, Transient inhibition of chromosome damage repair after ionizing radiation by gemcitabine. Proceedings of the American Association for Cancer Research, 36, 612.
20. HUANG, P., CHUBB, S. and PLUNKETT, W., 1990, Termination of DNA synthesis by 9-β-D-arabinofuranosyl-2-fluoroadenosine: a mechanism for cytotoxicity. Journal of Biological Chemistry, 265, 16617-16625.
21. HUANG P., CHUBB S., HERTEL L. W., GRINDEY G. B. and PLUNKETT W., 1991, Action of 2′,2′-difluorodeoxycytidine on DNA synthesis. Cancer Research, 51, 6110-6117.
22. HUANG, P. and WRIGHT, S., 1997, Induction of apoptosis by nucleoside analogs. In Nucleoside Analogs in Cancer Therapy, edited by B. D. Cheson, M. J. Keating and W. Plunkett (New York: Marcel Dekker), pp. 37-72.
23. ILIAKIS, G. and BRYANT, P. E., 1983, Effects of the nucleoside analogues a-Ara-A, b-Ara-A and b-Ara-C on cell growth and repair of both potentially lethal damage and DNA double strand breaks in mammalian cells in culture. Anticancer Research, 3, 143-150.
24. ILIAKIS, G., PANTELIAS, G., OKAYASU, R. and SEANER, R., 1989, Comparative studies on repair inhibition by araA, araC and aphidicolin of radiation induced DNA and chromosome damage in rodent cells: comparison with fixation of PLD. International Journal of Radiation Oncology, Biology, Physics, 16, 1261-1265.
25. JAYANTH, R. V. and HITTELMAN, W. N., 1991, 9-β-D-arabinofuranosyl-2-fluroadenine (F-ara-A) inhibits both the fast and slow components of chromosome repair. In Radiation Research: A Twentieth-Century Perspective, vol. 1, edited by J. D. Chapman, W. C. Dewey and G. F. Whitmore (San Diego: Academic), pp. 411.
26. KINSELLA, T. J., MITCHELL, J. B., RUSSO, A., MORSTYN, G. and GLASTEIN, E., 1984, The use of halogenated thymidine analogs as clinical radiosensitizers: rationale, current status and future prospects: nonhypoxic sensitizers. International Journal of Radiation Oncology, Biology, Physics, 10, 1399-1406.
27. LAWRENCE, T. S., CHANG, K. Y., HAHN, T. M., HERTEL, L. W. and SHEWACH, D. S., 1996, Radiosensitization of pancreatic cancer cells by 2′,2′-difluoro-2′-deoxycytidine. International Journal of Radiation Oncology, Biology, Physics, 34, 867-872.
28. LAWRENCE, T. S., CHANG, E., HAHN, T. M. and SHEWACH, D. S., 1997, Delayed radiosensitization of human colon carcinoma cells after a brief exposure to 2′,2′-difluoro-2′-deoxycytidine (gemcitabine). Clinical Cancer Research, 3, 777-782.
29. MCGINN, C. J., SHEWACH, D. S. and LAWRENCE, T. S., 1996, Radiosensitizing nucleosides. Journal of the National Cancer Institute, 88, 1193-1203.
30. MCLARTY, J. W. and THAMES, H. D., 1977, A parametric method for estimation of dose-modifying factors: low-dose extrapolation limit. Radiation Research, 69, 1-15.
31. MILAS L., HUNTER N., MASON K. A., MILROSS C. and PETERS L. J., 1995, Tumor reoxygenation as a mechanism of taxol-induced enhancement of tumours radioresponse. Acta Oncolologica, 34, 409-4012.
32. MOZDARANI H. and BRYANT P. E., 1987, The effect of 9-beta-D-arabinofuranosyladenine on the formation of X-ray induced chromatid aberrations in X-irradiated G2 human cells. Mutagenesis, 2, 371-374.
33. MULLEN, J., XU, Y. Z., LEPEK, K., PLUNKETT, W. and RICH, T., 1994, Cytotoxicity and radiosensitization by Gemcitabine in exponential human colon adenocarcinoma (clone A) cells. Proceedings of the 42nd Annual Meeting of the Radiation Research Society, Nashville, April 29-May 4, pp. 206.
34. OSTRUSZKA, L. J. and SHEWACH, D. S., 1997, Cytotoxicity and radiosensitization of gemcitabine in human glioblastoma cell lines. Proceedings of the American Association for Cancer Research, 38, 683.
35. PETERS, G. J AND ACKLAND, S. P., 1996, New antimetabolites in preclinical and clinical development. Exp. Opinion in Investigation Drugs. 5, 637-679.
36. PLUNKETT, W., HUANG, P., XU, Y-Z., HEINEMAN, V., GRUNEWALD, R. and GANDHI, V., 1995, Gemcitabine: metabolism, mechanisms of action and self-potentiation. Seminar in Oncology, 22 (suppl. 11), 3-10.
37. PLUNKETT, W. and GANDHI, V., 1997, Nucleoside analogs: cellular pharmacology, mechanisms of action and strategies for combination therapy. In Nucleoside Analogs in Cancer Therapy, edited by B. D. Cheson, M. J. Keating and W. Plunkett (New York: Marcel Dekker), pp. 1-36.
38. PRESTON, R. J., 1983, Radiation damage to DNA and its repair in the formation of chromosome aberrations. In Radiation-Induced Chromosome Damage in Man, edited by A. R. Lin (New York: Alan R. Liss), pp. 111-125.
39. ROCKWELL, S. and GRINDEY, G. B., 1992, Effect of 2′,2′-difluorodeoxycytidine on the viability and radiosensitivity of EMT6 cells in vitro. Oncology Research, 4, 151-155.
40. ROSIER, J. K., BEAUDUIN, M., DE BAST, M., DE COSTER, B., OCTAVE, M., SCALLIET, P. and GRÉGOIRE, V., 1997, Radiosensitization by gemcitabine (dFdC) of radiosensitive (RS) and radioresistant (RR) human head and neck squamous carcinoma (HNSC) cell lines. Proceedings of the American Association for Cancer Research, 38, 298.
41. RUIZ VAN HAPPEREN V. W. T., VEERMAN G., BOVEN E., NOORDHUIS P., VERMOKEN J. B. and PETERS G. J., 1994, Schedule dependence of sensitivity to 2′,2′-Difluorodeoxycytidine (gemcitabine) in relation to accumulation and retention of its triphosphate in solid tumour cell lines and solid tumours. Biochemical Pharmacology, 48, 1327-1839.
42. SANDOVAL, A.,CONSOLI, U. and PLUNKETT, W., 1996, Fludarabine-mediated inhibition of nucleotide excision repair induces apoptosis in quiescent human lymphocytes. Clinical Cancer Research, 2, 1731-1741.
43. SHEWACH, D. S., HAHN, T. M., CHANG, E., HERTEL, L. W. and LAWRENCE, T. S., 1904, Metabolism of 2′,2′-difluoro-2′-deoxycytidine and radiation sensitization of human colon carcinoma cells. Cancer Research, 54, 3218-3223.
44. SHEWACH, D. S. and LAWRENCE, T. S., 1995, Radiosensitization of human tumours cells by gemcitabine in vitro. Seminar in Oncology, 22 (suppl. II), 68-71.
45. TSENG, W. C., DERSE, D., CHENG, Y. C., BROCKMAN, R. W. and BENNETT, L. L. JR., 1982, In vitro biological activity of 9-β-D-arabinofuranosyl-2-fluoroadenosine and the biochemical actions of its triphosphate on DNA polymerases and ribonucleotide reductase from HeLa cells. Molecular Pharmacology, 21, 474-477.
46. WARD, J. F., JONER, E. I. and BLAKELY, W. F., 1984, Effects of inhibitors of DNA strand break repair on HeLa cell radiosensitivity. Cancer Research, 44, 59-63.
47. WARD, J. F., 1985, Biochemistry of DNA lesions. Radiation Research, 104, S103-111.
48. WARD, J. F., 1988, DNA damage produced by ionizing radiation in mammalian cells: identities, mechanisms of formation and reparability. Progress in Nucleic Acid Molecular Biology, 35, 95-125.
49. WEBSTER, L. K., JOSCHKO, M. A., GROVES, J., YCEN, K., BISHOP, J. F., BALL, D. L. and MILLWARD M. J., 1997, Radioenhancement by gemcitabine with accelerated fractionated radiotherapy in a human tumours xenografi. Proceedings of the American Association for Cancer Research, 38, 248.
50. WOOD, R. D., 1996, DNA repair in eukaryotes. Annual Review in Biochemistry, 65, 135-167.
51. YANG, S. W., HUANG, P., PLUNKETT, W., BECKER, F. F. and CHAN, J. Y. H., 1992, Dual mode of inhibition of purified DNA ligase I from human cells by 9-β-D-arabinofuranosyl-2-fluoroadenosine. Journal of Biological Chemistry, 267, 2345-2349.